Multiple-dose Study to Evaluate the Efficacy, Safety and Pharmacokinetics of BMS-646256 in Obese Subjects

NCT ID: NCT00388609


Title
A Randomized, Double-blind, Placebo-Controlled, Parallel Arm, Multiple-Dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BMS-646256 in Obese and High Risk Overweight Subjects
Purpose
The purpose of this study is to learn if BMS-646256 can cause weight loss in men and women who are: - overweight with high blood pressure or high cholesterol or - obese The safety of this treatment will also be studied
Details
Conditions
Obesity
Keywords
Source
Bristol-Myers Squibb
Sponsors
Bristol-Myers Squibb, Solvay Pharmaceuticals
Status
Terminated
Acronym
Last Updated
14 Sep 2010
URL
Official Link
Locations
United States